Another research project found that mice treated with Epitalon had more active, longer telomeres
You're not just thinking about whether you remembered to pack it you're thinking about whether it's still viable, whether the injection timing still works across time zones, and whether the person at airport security is going to make the next five minutes interesting
Retatrutide TRIUMPH-1 (2023) and TRIUMPH-2 (2024) TRIUMPH-1 (Jastreboff et al., NEJM 2023): 338 non-diabetic adults with obesity, 48 weeks at escalating doses: 12 mg dose: 24.2% weight loss 8 mg dose: 22.8% 4 mg dose: 17.5% Placebo: 2.1% TRIUMPH-2 (Rosenstock et al., Lancet 2024) confirmed effects in T2D patients with concurrent NAFLD improvement (hepatic fat reduction 54% at 24 weeks, 12 mg dose)
The 28.7% at 68 weeks in TRIUMPH-4 is observed in a specific population (obesity + knee OA)
pEC 50 values were calculated using the three parameter log(agonist) vs response model in GraphPad Prism9 (version 9.1.0
Refund requests can be submitted via our Contact Us page and will be subject to our refund policies